Metabolic Downregulation : A Key to Successful Neuroprotection?

Journal article

Open access

Peer reviewed

Midori YENARI, Kazuo KITAGAWA, Patrick LYDEN and Miguel PEREZ-PINZON

Stroke (1970), Vol.39(10), pp.2910-2917

2008

PMCID: PMC2597567

PMID: 18658035

Abstract

Neurology

Pharmacology. Drug treatments

Biological and medical sciences

Neuroprotective agent

Vascular diseases and vascular malformations of the nervous system

Medical sciences

Neuropharmacology

url

https://doi.org/10.1161/STROKEAHA.108.514471View

Published (Version of record) Open

8 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.134 Trauma & Emergency Surgery; 1.134.600 Cardiopulmonary Resuscitation
Web Of Science research areas: Clinical Neurology; Peripheral Vascular Disease
ESI research areas: Neuroscience & Behavior

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Metabolic Downregulation : A Key to Successful Neuroprotection?
Creators: Midori YENARI - Department of Neurology University of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, Calif, United States
Kazuo KITAGAWA - Department of Neurology Osaka University Graduate School of Medicine, Suita, Osaka, Japan
Patrick LYDEN - Neurology and Research Services of the San Diego Veteran's Administration Medical Center and the Department of Neurosciences University of California, San Diego, United States
Miguel PEREZ-PINZON - Department of Neurology University of Miami, Fla, United States
Publication Details: Stroke (1970), Vol.39(10), pp.2910-2917
Publisher: Lippincott Williams & Wilkins; Hagerstown, MD
Academic Unit: Miller School of Medicine; UMMG Department of Neurology
Language: English
Resource Type: Journal article
PMID: 18658035
PMCID: PMC2597567
Record Identifier: 991031560833202976